# Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients

> **NCT00337116** · PHASE4 · WITHDRAWN · sponsor: **Soroka University Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Unstable Angina
- Myocardial Infarction

## Interventions

- **DRUG:** iso sorbide dinitrate iv bolus or s/l

## Key facts

- **NCT ID:** NCT00337116
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-01
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** LOGISTIC DIFFICULTIES
- **Last updated:** 2010-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337116, "Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00337116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*